Records
Browse every document routed through Assort Design.
Route Filters
Study calls for new gold standard in research to treat non-alcoholic steatohepatitis Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About F
One-line summary: The study advocates a new human-relevant gold standard using in vitro and omics techniques to better understand and treat non-alcoholic steatohepatitis (NASH), addressing limitations of current animal models.
Citations: 2 · Risk: 1 High / 1 Medium / 0 Low
Madrigal Expands its MASH Pipeline with Exclusive Global Accessibility: Skip TopNav Consumer Products and Services News Automobiles and Parts News Food & Beverage News Home Goods & Construction News L
One-line summary: Madrigal Pharmaceuticals broadens its MASH treatment pipeline by securing exclusive global rights to six preclinical siRNA programs, complementing its foundational drug Rezdiffra and aiming for genetically targeted MASH therapies.
Citations: 5 · Risk: 1 High / 0 Medium / 0 Low